Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002440
What this trial is testing

1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 80
Testing effectiveness (Phase 2)Study completedNCT00000870
What this trial is testing

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Early research (Phase 1)Study completedNCT00002365
What this trial is testing

LXR015-1 in HIV-Infected Patients

Who this might be right for
HIV Infections
LXR Biotechnology 30
Testing effectiveness (Phase 2)Study completedNCT00001057
What this trial is testing

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 105
Early research (Phase 1)Study completedNCT00006066
What this trial is testing

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Large-scale testing (Phase 3)Study completedNCT00004581
What this trial is testing

Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

Who this might be right for
HIV Infections
Abbott 300
Large-scale testing (Phase 3)Study completedNCT00002195
What this trial is testing

Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome 290
Not applicableStudy completedNCT00386035
What this trial is testing

Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 883
Not applicableStudy completedNCT00050908
What this trial is testing

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Not applicableStudy completedNCT00001117
What this trial is testing

Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT00053443
What this trial is testing

Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Not applicableStudy completedNCT00414518
What this trial is testing

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

Who this might be right for
HIV Infections
University of Colorado, Denver 16
Testing effectiveness (Phase 2)Study completedNCT00036452
What this trial is testing

Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 402
Not applicableStudy completedNCT00004855
What this trial is testing

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT00102206
What this trial is testing

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Early research (Phase 1)Study completedNCT01275443
What this trial is testing

Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.

Who this might be right for
HIV Infection
St Stephens Aids Trust 66
Testing effectiveness (Phase 2)UnknownNCT00002241
What this trial is testing

Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 80
Testing effectiveness (Phase 2)Study completedNCT00099645
What this trial is testing

Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT00000944
What this trial is testing

Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00002209
What this trial is testing

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

Who this might be right for
AIDS Dementia ComplexHIV Infections
Centaur Pharmaceuticals 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation